Skip to Main content Skip to Navigation
Journal articles

Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness

Abstract : Aim: DNA methylation is a fundamental biologic process of genomes and is a candidate for pharmacological manipulation that might have important therapeutic advantages. Thus, DNA methyltransferases (DNMTs) appear to be ideal targets for drug intervention. Materials & methods: To develop a new generation of DNMT inhibitor, we analyzed the ability of peptides to selectively inhibit certain DNMT1-incuding complexes. Results: Our study demonstrates that the disruption of DNMT1/CFP1-including complexes increases the efficiency of chemotherapeutic treatment on established tumors in mice. Conclusion: Our data opens a promising and innovative alternative to the development of DNMT inhibitors
Complete list of metadatas

https://www.hal.inserm.fr/inserm-02478615
Contributor : Pierre-Francois Cartron <>
Submitted on : Friday, February 14, 2020 - 6:21:37 AM
Last modification on : Friday, June 19, 2020 - 3:25:00 AM

Identifiers

Citation

Pierre-Francois Cartron, Mathilde Cheray, Arulraj Nadaradjane, Pascal Bonnet, Sylvain Routier, et al.. Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness. Epigenomics, Future Medicine, 2014, 6 (3), pp.267-275. ⟨10.2217/epi.14.18⟩. ⟨inserm-02478615⟩

Share

Metrics

Record views

80